Skip to main content
Equibles

Alyeska Investment Group, L.P.

Position in GMAB — Genmab A/S

CIK 1453072 CHICAGO, IL
Back to GMAB Full portfolio

Position in GMAB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$22,096,153
+$4,777,898 QoQ
Shares Held
804,374
+24.6% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#27
of 292 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Alyeska Investment Group, L.P. holds $989,063,778 across 83 Biotechnology names. GMAB ranks #11 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 659,279 $123,469,771
2 IONS
Ionis Pharmaceuticals Inc
 1,417,916 $112,426,559
3 PTGX
Protagonist Therapeutics, Inc
 889,298 $109,010,148
4 XENE
Xenon Pharmaceuticals Inc.
 697,692 $42,112,689
5 MRNA
Moderna, Inc.
 560,819 $39,274,154
6 KYMR
Kymera Therapeutics, Inc.
 276,455 $31,701,094
7 LBRX
Lb Pharmaceuticals Inc
 863,947 $28,039,399
8 PRAX
Praxis Precision Medicines, Inc.
 80,846 $27,066,432

All Filings in GMAB

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,096,153 804,374
2026-03-31 $17,318,255 645,481
2025-12-31 $15,605,158 506,661